Antidepressant may prevent severe COVID-19 (IMAGE)

University of Virginia Health System

Antidepressant may prevent severe COVID-19

Caption

A discovery by Alban Gaultier, PhD, of the University of Virginia School of Medicine, prompted a clinical trial of the antidepressant fluvoxamine for the treatment of COVID-19.

Credit

Dan Addison | UVA Communications

Usage Restrictions

May be used to accompany news coverage of the COVID-19 trial results. All other uses require express written permission from UVA Health.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.